Dimensional Fund Advisors LP Trims Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE)
Dimensional Fund Advisors LP lowered its position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 13.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 259,970 shares of the biopharmaceutical company’s stock after selling 39,895 shares during the period. Dimensional Fund […]
Dimensional Fund Advisors LP lowered its position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 13.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 259,970 shares of the biopharmaceutical company’s stock after selling 39,895 shares during the period. Dimensional Fund […]
